Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure

Kenichi Matsushita, Kazumasa Harada, Tetsuro Miyazaki, Takamichi Miyamoto, Shun Kosaka, Kiyoshi Iida, Shuzou Tanimoto, Makoto Takei, Toru Hosoda, Yoshiya Yamamoto, Yasuyuki Shiraishi, Hideaki Yoshino, Takeshi Yamamoto, Ken Nagao, Morimasa Takayama

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVE: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (+) and without (-) high blood pressure (HBP). METHODS: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50%; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P < 0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. RESULTS: In-hospital mortality was significantly lower for HFpEF + HBP than HFpEF - HBP patients (log-rank, P < 0.001). Independent risk factors for in-hospital mortality in HFpEF + HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without beta-blockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. CONCLUSION: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.

Original languageEnglish
Pages (from-to)643-649
Number of pages7
JournalJournal of Hypertension
Volume37
Issue number3
DOIs
Publication statusPublished - 2019 Mar 1
Externally publishedYes

Fingerprint

Diuretics
Heart Failure
Hypertension
Hospital Mortality
Therapeutics
Blood Pressure
Tokyo
Brain Natriuretic Peptide
C-Reactive Protein
Registries
Regression Analysis
Phenotype
Survival

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure. / Matsushita, Kenichi; Harada, Kazumasa; Miyazaki, Tetsuro; Miyamoto, Takamichi; Kosaka, Shun; Iida, Kiyoshi; Tanimoto, Shuzou; Takei, Makoto; Hosoda, Toru; Yamamoto, Yoshiya; Shiraishi, Yasuyuki; Yoshino, Hideaki; Yamamoto, Takeshi; Nagao, Ken; Takayama, Morimasa.

In: Journal of Hypertension, Vol. 37, No. 3, 01.03.2019, p. 643-649.

Research output: Contribution to journalArticle

Matsushita, K, Harada, K, Miyazaki, T, Miyamoto, T, Kosaka, S, Iida, K, Tanimoto, S, Takei, M, Hosoda, T, Yamamoto, Y, Shiraishi, Y, Yoshino, H, Yamamoto, T, Nagao, K & Takayama, M 2019, 'Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure', Journal of Hypertension, vol. 37, no. 3, pp. 643-649. https://doi.org/10.1097/HJH.0000000000001932
Matsushita, Kenichi ; Harada, Kazumasa ; Miyazaki, Tetsuro ; Miyamoto, Takamichi ; Kosaka, Shun ; Iida, Kiyoshi ; Tanimoto, Shuzou ; Takei, Makoto ; Hosoda, Toru ; Yamamoto, Yoshiya ; Shiraishi, Yasuyuki ; Yoshino, Hideaki ; Yamamoto, Takeshi ; Nagao, Ken ; Takayama, Morimasa. / Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure. In: Journal of Hypertension. 2019 ; Vol. 37, No. 3. pp. 643-649.
@article{4ff516827e824c9ea66ae2d346583946,
title = "Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure",
abstract = "OBJECTIVE: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (+) and without (-) high blood pressure (HBP). METHODS: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50{\%}; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P < 0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. RESULTS: In-hospital mortality was significantly lower for HFpEF + HBP than HFpEF - HBP patients (log-rank, P < 0.001). Independent risk factors for in-hospital mortality in HFpEF + HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without beta-blockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. CONCLUSION: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.",
author = "Kenichi Matsushita and Kazumasa Harada and Tetsuro Miyazaki and Takamichi Miyamoto and Shun Kosaka and Kiyoshi Iida and Shuzou Tanimoto and Makoto Takei and Toru Hosoda and Yoshiya Yamamoto and Yasuyuki Shiraishi and Hideaki Yoshino and Takeshi Yamamoto and Ken Nagao and Morimasa Takayama",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/HJH.0000000000001932",
language = "English",
volume = "37",
pages = "643--649",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure

AU - Matsushita, Kenichi

AU - Harada, Kazumasa

AU - Miyazaki, Tetsuro

AU - Miyamoto, Takamichi

AU - Kosaka, Shun

AU - Iida, Kiyoshi

AU - Tanimoto, Shuzou

AU - Takei, Makoto

AU - Hosoda, Toru

AU - Yamamoto, Yoshiya

AU - Shiraishi, Yasuyuki

AU - Yoshino, Hideaki

AU - Yamamoto, Takeshi

AU - Nagao, Ken

AU - Takayama, Morimasa

PY - 2019/3/1

Y1 - 2019/3/1

N2 - OBJECTIVE: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (+) and without (-) high blood pressure (HBP). METHODS: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50%; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P < 0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. RESULTS: In-hospital mortality was significantly lower for HFpEF + HBP than HFpEF - HBP patients (log-rank, P < 0.001). Independent risk factors for in-hospital mortality in HFpEF + HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without beta-blockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. CONCLUSION: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.

AB - OBJECTIVE: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (+) and without (-) high blood pressure (HBP). METHODS: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50%; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P < 0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. RESULTS: In-hospital mortality was significantly lower for HFpEF + HBP than HFpEF - HBP patients (log-rank, P < 0.001). Independent risk factors for in-hospital mortality in HFpEF + HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without beta-blockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. CONCLUSION: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.

UR - http://www.scopus.com/inward/record.url?scp=85060935009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060935009&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000001932

DO - 10.1097/HJH.0000000000001932

M3 - Article

VL - 37

SP - 643

EP - 649

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 3

ER -